Log in
Enquire now
OMass Therapeutics

OMass Therapeutics

A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
Rosamond Deegan
Rosamond Deegan
Company Operating Status
Active
Competitors
Oxford Drug Design Limited
Oxford Drug Design Limited
Country
United Kingdom
United Kingdom
Crunchbase URL
crunchbase.com/organiz...nologies
Date Incorporated
February 26, 2016
Email Address
info@omass.com
Founded Date
2012
Founder
Idlir Liko
Idlir Liko
Full Address
Schrödinger Building Heatley Road, Oxford Science Park, Oxford, England, OX4 4GE
Glassdoor ID
4929913
Incorporation Reference
10028228
Industry
Biology
Biology
Technology
Technology
Engineering
Engineering
Mass spectrometry
Mass spectrometry
Drug discovery
Drug discovery
Therapeutics
Therapeutics
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Investors
Syncona Investment Management
Syncona Investment Management
OSI (Oxford Sciences Innovation)
OSI (Oxford Sciences Innovation)
University of Oxford
University of Oxford
Scott Biller
Scott Biller
0
Northpond Ventures
Northpond Ventures
Google Ventures
Google Ventures
Sanofi Ventures
Sanofi Ventures
Latest Funding Round Date
April 28, 2022
Latest Funding Round Amount (USD)
100,000,000
Latest Funding Type
Series B
Series B
Legal classification
Private limited company
Private limited company
LinkedIn URL
@company/omass-therapeutics/about
Location
United Kingdom
United Kingdom
Oxford
Oxford
Phone Number
+441157849386
Total Funding Amount (USD)
100,000,000
Twitter URL
@omasstx
UKSIC Code
72110
Official Website
omass.com

Find more companies like OMass Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.